Loading...

Bactiguard Holding AB (publ)

0QV2.LLSE
Healthcare
Medical - Equipment & Services
£74.00
£12.00(19.35%)

Bactiguard Holding AB (publ) (0QV2.L) Financial Performance & Income Statement Overview

Explore the financials of Bactiguard Holding AB (publ) (0QV2.L), including yearly and quarterly data on income, cash flow, and balance sheets.

Revenue Growth
19.46%
19.46%
Operating Income Growth
78.13%
78.13%
Net Income Growth
78.45%
78.45%
Operating Cash Flow Growth
147.75%
147.75%
Operating Margin
-8.05%
8.05%
Gross Margin
63.64%
63.64%
Net Profit Margin
-9.53%
9.53%
ROE
-7.56%
7.56%
ROIC
-4.33%
4.33%

Bactiguard Holding AB (publ) (0QV2.L) Income Statement & Financial Overview

Review Bactiguard Holding AB (publ) 0QV2.L income statement with detailed quarterly and annual figures.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$59.05M$68.26M$73.94M$57.35M
Cost of Revenue$10.97M$5.46M$7.20M$70.40M
Gross Profit$48.08M$62.80M$66.74M-$13.05M
Gross Profit Ratio$0.81$0.92$0.90-$0.23
R&D Expenses$0.00$0.00$0.00$6.30M
SG&A Expenses$0.00$0.00$0.00$46.48M
Operating Expenses$50.70M$66.001M$68.68M$59.88M
Total Costs & Expenses$61.66M$71.46M$75.88M$70.40M
Interest Income$16000.00$4.11M$0.00$0.00
Interest Expense$4.88M$3.26M$4.19M$5.04M
Depreciation & Amortization$12.02M$8.10M$19.03M$12.06M
EBITDA$9.43M$12.54M$17.09M-$989000.00
EBITDA Ratio$0.16$0.18$0.23-$0.02
Operating Income-$2.61M-$3.20M-$1.94M-$13.05M
Operating Income Ratio-$0.04-$0.05-$0.03-$0.23
Other Income/Expenses (Net)-$4.87M$844000.00-$4.19M-$5.04M
Income Before Tax-$7.48M-$2.36M-$6.13M-$15.89M
Income Before Tax Ratio-$0.13-$0.03-$0.08-$0.28
Income Tax Expense-$2.75M-$1.44M-$1.46M-$1.57M
Net Income-$4.73M-$920000.00-$4.67M-$14.32M
Net Income Ratio-$0.08-$0.01-$0.06-$0.25
EPS-$0.13-$0.03-$0.13-$0.41
Diluted EPS-$0.13-$0.03-$0.13-$0.41
Weighted Avg Shares Outstanding$35.04M$35.04M$35.04M$35.04M
Weighted Avg Shares Outstanding (Diluted)$35.04M$35.04M$35.04M$35.04M

Over the last four quarters, Bactiguard Holding AB (publ)'s revenue moved from $57.35M in Q2 2024 to $59.05M in Q1 2025. Operating income in Q1 2025 was -$2.61M, with a strong operating margin of -4%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Bactiguard Holding AB (publ) remained robust at $9.43M, reflecting operational efficiency. Net income dropped to -$4.73M, with an EPS of -$0.13. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;